Stock search

Ticker or company name

Compare stocks

Market: US

  • ZBHZimmer Biomet

Add stock

Ticker or company

Summary

ZBH
Zimmer Biomet
$101,41Down −1,74%
Year: Up +14%
67/100Ratio would watch
Open stock page

Traffic light — 10 checks

CheckZBH4 ✓ 4 — 1 ✕
P/E vs its history26,0
P/E vs industry26,0
Forward P/E10,5
Revenue growth, YoY+7,0%
EPS growth, YoY−1,7%
Net margin9,0%
Net debt / EBITDA2,6
Free cash flow$1,64 bn
Share count over a year−3,7%
Cash runwayn/anot needed

Metrics

Best WorstNo mark — in between

Metric · betterZBHTTMIndustry medianTTM
P/E TTM ↓26,025,1
Forward P/E ↓10,516,2
PEG ↓4,32,2
P/S TTM ↓2,32,2
EV/EBITDA ↓14,817,3
P/FCF ↓17,219,5

Price, %

  • ZBHn/a

Returns

Best WorstNo mark — in between

PeriodZBH
1 yearn/a
3 yearsn/a
5 yearsn/a
All timen/a

“Per year” is the average annual return: 90% growth over 3 years is 23,9% per year, not 30%. “All time” starts at the IPO, so only “per year” compares fairly. Prices adjusted for splits, dividends reinvested.

Analysts and insiders

Best WorstNo mark — in between

ZBH
Share of “buy”32%
Beat the forecast3 of 4
Average “surprise”+3,2%
Insiders over 12 monthssales $1,58 m

Details are on each stock page.